v3.26.1
Shareholders' Equity
 6 Months Ended
Jun. 28, 2026
Equity [Abstract]  
Shareholders' Equity Shareholders’ Equity
Earnings per Share
The following table sets forth the computation of basic and diluted earnings per share:
Three Months EndedSix Months Ended
June 28, 2026June 29, 2025June 28, 2026June 29, 2025
Numerator:
Net income from continuing operations$105,024 $68,651 $172,649 $117,968 
Net (income)/loss from continuing operations attributable to noncontrolling interests(130)224 (154)164 
Net income from continuing operations attributable to Sonoco$104,894 $68,875 $172,495 $118,132 
Net income attributable to Sonoco$104,894 $493,423 $172,495 $547,852 
Denominator:
Weighted average common shares outstanding:
Basic99,478 99,171 99,397 99,055 
Dilutive effect of shared-based compensation303 368 351 398 
Diluted 99,781 99,539 99,748 99,453 
Per common share:
Basic earnings per common share:
Net income from continuing operations$1.05 $0.69 $1.74 $1.19 
Net income attributable to Sonoco$1.05 $4.97 $1.74 $5.53 
Diluted earnings per common share:
Net income from continuing operations$1.05 $0.69 $1.73 $1.19 
Net income attributable to Sonoco$1.05 $4.96 $1.73 $5.51 
Cash dividends$0.54 $0.53 $1.07 $1.05 
No adjustments were made to “Net income attributable to Sonoco” in the computations of net income attributable to Sonoco per common share.
Anti-dilutive Securities
Potentially dilutive securities are calculated in accordance with the treasury stock method, which assumes the proceeds from the exercise of all dilutive stock appreciation rights (“SARs”) are used to repurchase the Company’s common stock. Certain SARs are not dilutive because either the exercise price is greater than the average market price of the stock during the reporting period or assumed repurchases from proceeds from the exercise of the SARs were anti-dilutive. These SARs may become dilutive in the future if the market price of the Company’s common stock appreciates.
The average numbers of SARs that were anti-dilutive and, therefore, not included in the computation of diluted earnings per share during the three- and six-month periods ended June 28, 2026 and June 29, 2025 were as follows (in thousands):
Three Months EndedSix Months Ended
June 28, 2026June 29, 2025June 28, 2026June 29, 2025
Anti-dilutive stock appreciation rights388 515 392 532 
Stock Repurchases
On April 20, 2021, the Company’s Board of Directors (the “Board”) authorized the repurchase of the Company’s common stock in an aggregate amount of up to $350,000. Following several repurchase transactions in 2021, a total of $137,972 remained available for share repurchases under this authorization as of December 31, 2021. Subsequent to 2021, no additional shares have been repurchased under this authorization.
The Company regularly repurchases shares of its common stock to satisfy employee tax withholding obligations in association with certain share-based compensation awards. These repurchases, which are not part of a publicly announced plan or program, totaled 132 shares during the six-month period ended June 28, 2026, at a cost of $7,011, and 220 shares during the six-month period ended June 29, 2025, at a cost of $10,576.
Dividend Declarations
On February 11, 2026, the Board declared a regular quarterly dividend of $0.53 per share. This dividend was paid on March 10, 2026 to all shareholders of record as of February 25, 2026.
On April 15, 2026, the Board declared a regular quarterly dividend of $0.54 per share. This dividend was paid on
June 10, 2026 to all shareholders of record as of May 8, 2026.
On July 15, 2026, the Board declared a regular quarterly dividend of $0.54 per share. This dividend will be paid on September 10, 2026 to all shareholders of record as of August 10, 2026.